Joel Greenblatt’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Joel Greenblatt's KNSA Position: Q3 2026 in Review
Joel Greenblatt reduced its Kiniksa Pharmaceuticals (KNSA) stake by 12% in Q3 2026, selling an estimated $42.7K and leaving 4,219 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.
Joel Greenblatt first reported a position in KNSA in Q2 2025 and has held it in 6 quarters since. The position peaked at $406K in Q2 2025. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Joel Greenblatt held 4,219 shares of Kiniksa Pharmaceuticals worth $315K as of Q3 2026.
- Joel Greenblatt sold 580 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $42.7K.
- Kiniksa Pharmaceuticals made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1699 holding.
- Joel Greenblatt first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- Joel Greenblatt's Kiniksa Pharmaceuticals position peaked at $406K in Q2 2025.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.